Page properties |
---|
Status | In progressReady for implementation |
---|
Version | 1.0.1 |
---|
|
Descriptions:
Term | description type | Language/acceptability | LangaugeLanguage/acceptability | Case significance |
---|
[Accidental/Intentional] [course] [substance or product] overdose overdose (disorder) | FSN | us:P | gb:P | ci |
[Accidental/Intentional] [course] [substance or product] overdose overdose | SYN | us:P | gb:P | ci |
Concept model:
Attribute Group Cardinality | Attribute Cardinality cardinality | Attribute cardinality in role groupGroup Cardinality | Attribute | Value |
---|
10..0 | 10..01 |
|
Scg expression |
---|
116680003 |Is a (attribute)| |
|
Scg expression |
---|
1149222004 |Overdose (disorder)| |
|
0..1 |
| 0..1 |
Scg expression |
---|
263502005 |Clinical course (attribute)| |
|
Scg expression |
---|
< 288524001 |Courses (qualifier value)| |
|
0..1 |
| 0..1 |
Scg expression |
---|
42752001 |Due to (attribute)| |
|
Scg expression |
---|
<< 1148742001 |Intentional event (event)| OR << 418019003 |Accidental event (event)| |
|
0..*1 |
| 0..1 |
Scg expression |
---|
246075003|Causative agent (attribute)| |
|
Scg expression |
---|
[agent] << 105590001|Substance (substance)| OR << 373873005|Pharmaceutical / biologic product (product)| |
|
...
Scg expression |
---|
1149222004 |Overdose (disorder)|:
[[~0..1]] {[[~0..1]] 263502005 |Clinical course (attribute)| = [[ +id ( < 288524001 |Courses (qualifier value)|) @course]]},
[[~0..1]] {[[~0..1]] 42752001 |Due to (attribute)| = [[+id ( << 1148742001 |Intentional event (event)| OR << 418019003 |Accidental event (event)|) @dueto ]]},
[[~0..*1]] {[[~0..1]] 246075003 |Causative agent (attribute)| = [[+id ( < 105590001 |Substance (substance)| OR < 373873005 |Pharmaceutical / biologic product (product)|) @causative]]} |
Link to the misaligned concept report
Overdose misaligned concept report 2021-Dec-14
Rules for generating descriptions:
...
The following editorial guidelines apply to concepts in the International Release; editorial guidelines for concepts in national extensions may vary.
Causative agent type | Allowed | Exception | Examples and Notes (Note: Examples are existing concepts and may not reflect the terming patterns described in the template.) |
---|
Substance |
baseOverdose concepts representing a substance base should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.Substance modification | no, unless documented as exception | Overdose concepts representing a substance modification should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. n/a | Example: - 295184007 |Morphine overdose (disorder)|
|
Expected classification:
- Classification results are expected to be consistent with the modeling of the concept selected as the Causative agent in the Substance hierarchy.
Substance | Modification | yes | yes |
Concepts representing substance modifications are exceptions and may be included if the overdose profile is significantly different from the substance base. Exception examples: - Liposome or lipid complex substances (e.g. 412088006 |Amphotericin B liposome (substance)|, 426490000 |Vincristine liposome (substance)|)
- Pegylated substance (e.g. 385544005 |Pegfilgrastim (substance)|, 770965008 |Pegvaliase (substance)|)
- Salt forms (e.g. 273948005 |Chloral hydrate (substance)|, 396063006 |Fluphenazine decanoate (substance)|)
Example: - 296136008 |Chloral hydrate overdose (disorder)|
- 296213007 |Fluphenazine decanoate overdose (disorder)|
|
Expected classification:
- Classification results are expected to reflect that the concept modeled with the modified substance is a descendant of the concept modeled with the base substance (if such a concept exists.
Multiple substanceyes | Overdose concepts representing multiple substances should be modeled using a GCIs, with Causative agent that is a descendant of 105590001 | (substance)|; preferentially modeling with the base rather than a modification unless the overdose profile is significantly different from the substance base.Example:
1149374003 |Dextropropoxyphene and/or paracetamol overdose (disorder)|1149371006 |Sulfamethoxazole and/or trimethoprim overdose (disorder)| | Disposition grouper | yes | n/a | Overdose concepts representing a disposition grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example: - 297053006 |Overdose of angiotensin-converting-enzyme inhibitors (disorder)|
- 296515004 |Opiate antagonist overdose (disorder)|
|
Expected classification results:Classification results are expected to be consistent with the modeling of the concept selected as the Causative agent in the hierarchy. | Role grouper | yes | n/a | Overdose concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. |
Note that role Classification results are expected to be consistent with the modeling of the concept selected as the Causative agent in the Role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release. Example: - 297006008 |Diuretic overdose (disorder)|
- 295217003 |Non-steroidal anti-inflammatory overdose (disorder)|
|
Expected classification results (to be revised when concepts are remodeled using Medicinal product ):
hierarchy. | Structure grouper | yes | n/a | Overdose concepts representing a structure grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example: - 295188005 |Pethidine analog overdose (disorder)|
- 1155996000 |Phenothiazine and/or phenothiazine derivative overdose (disorder)|
|
Expected classification:
- Classification results are expected to be consistent with the Substance hierarchy and with other existing concepts in the subhierarchy.
|
Product | Structure grouper | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
Product | Disposition grouper | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
Product | Role grouper | no | n/a | Overdose concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release. |
Product | Medicinal product-containing | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
Product | Medicinal product-only | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
Product | Medicinal product form-containing | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
Product | Medicinal product form-only | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
Product | Clinical drug | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
Descendant of 373873005 |Pharmaceutical / biologic product (product)| | no, unless documented as exception | Exceptions: None identified The following types of groupers are out of scope; existing concepts have been inactivated or will be addressed in future release:
...
- For the FSN, align terming and case sensitivity with the FSN for the concept that is selected as the attribute value, excluding the semantic tag.
- For the PT, align terming and case sensitivity with the US and GB PT for the concept that is selected as the attribute value.
- In cases where neither the US or GB PT matches the FSN, excluding the semantic tag, a synonym corresponding to the FSN is required unless explicitly identified as an exception.Additional synonyms "[agent] adverse reaction" should be added.
JIRA ticket for implementation:
Jira |
---|
server | IHTSDO JIRA |
---|
serverId | b202d822-d767-33be-b234-fec5accd5d8c |
---|
key | INFRA-8098 |
---|
|